Issues. Indigenous peoples of Australia, New Zealand, Canada and the United States experience a disproportionately high burden of harms from substance misuse. Research is therefore required to improve our understanding of substance use in Indigenous populations and provide evidence on strategies effective for reducing harmful use. Approach. A search of 13 electronic databases for peer-reviewed articles published between 1993 and 2014 focusing on substance use and Indigenous peoples of Australia, New Zealand, Canada and the United States. Relevant abstracts were classified as data or non-data based research. Data-based studies were further classified as measurement, descriptive or intervention and their trends examined by country and drug type. Intervention studies were classified by type and their evaluation designs classified using the Cochrane Effective Practice and Organisation of Care (EPOC) data collection checklist. Key Findings. There was a statistically significant increase from 1993 to 2014 in the percentage of total publications that were data-based (P < 0.001). Overall, data-based publications were mostly descriptive for all countries (84-93%) and drug types (74-95%). There were fewer measurement (0-4%) and intervention (0-14%) publications for all countries and the percentage of these did not change significantly over time. Forty-two percent of intervention studies employed an EPOC evaluation design. Implications. Strategies to increase the frequency and quality of measurement and intervention research in the Indigenous drug and alcohol field are required. Conclusion. The dominance of descriptive research in the Indigenous drug and alcohol field is less than optimal for generating evidence to inform Indigenous drug and alcohol policy and programs. [Clifford A, Shakeshaft A. A bibliometric review of drug and alcohol research focused on Indigenous peoples of Australia, New Zealand, Canada and the United States. Drug Alcohol Rev 2017;36:509-522] 
Introduction
Indigenous peoples of Australia, New Zealand, Canada and the United States experience a disproportionately high burden of drug and alcohol-related mortality [1] [2] [3] [4] [5] . Drug-and alcohol-related morbidity is also disproportionately higher among Indigenous peoples from these countries, including for example, foetal alcohol spectrum disorder [6, 7] , alcoholic cirrhosis [8, 9] , alcohol-related injury [10, 11] , tobacco-related cancers [3, 12] and mental disorders [3, 11] .
In addition to improving knowledge about the causes, levels and patterns of drug and alcohol use in Indigenous populations, research can also provide evidence about which intervention strategies are most cost-effective for reducing the deleterious health, social and psychological effects of drugs and alcohol on Indigenous peoples [13] . The extent to which research contributes to both describing harms and evaluating interventions aimed at reducing them will depend on research output in the Indigenous drug and alcohol field.
Examining the number and type of research publications in a specific area can provide a broad indication of research output [14] . The number of research publications that are data based, relative to those that are not, for example, can establish the amount of primary data available to contribute to the evidence. Moreover, the types of data-based studies (e.g. measurement, descriptive and intervention) published provide an indication of the type of evidence available. Examining the number of these types of publications in the Indigenous drug and alcohol research field would provide an indication as to the extent to which research has progressed from describing drug and alcohol issues in Indigenous populations, to establishing evidence of the effectiveness of intervention strategies designed to reduce drug and alcohol-related harms in Indigenous communities.
Study design is an indicator commonly used to assess the extent to which research evaluating the effectiveness of an intervention contributes to strengthening the evidence base [15] . Identifying the type of study designs used to evaluate drug and alcohol interventions targeting Indigenous peoples can provide an indication as to the strength of the Indigenous drug and alcohol evidence base [16] . It can also identify key gaps and areas for improvement. Such information may assist research and government funding agencies to identify priority study designs to strengthen the Indigenous drug and alcohol evidence base which, in turn, provides policy makers and health services with more reliable and valid evidence to inform drug and alcohol policies and programs targeting Indigenous peoples.
The overall aim of this review is to analyse the output of peer-reviewed drug and alcohol publications focused on Indigenous peoples of Australia, Canada, New Zealand and the United States for the period 1993-2014. Specifically, this review aims to: first, identify the number of drug and alcohol peer-reviewed publications focused on Indigenous peoples of Australia, New Zealand, Canada and the United States and the percentage of these that are data based; second, classify data-based studies as descriptive, measures or intervention research to determine the trend in these types of publications over time; and third, identify the foci, outcome measures and study design of intervention studies to determine the nature and quality of evidence available to inform Indigenous drug and alcohol policy and programs. Figure 1 summarises the databases searched, the search terms used, the exclusion criteria and classification of studies.
Methods

Search strategy
The search strategy was consistent with methods detailed in the Cochrane Collaboration Handbook on Systematic Reviews of Health Promotion and Public Health Interventions [15] . A qualified archivist identified 13 relevant electronic databases to search: APAIS-ATSIS, ATSIHealth, Campbell Library, CINAHL, Cochrane Database of Systematic Reviews, DRUG, Embase, Global Health, Medline, NDARC Library, Project Cork, PsycINFO and PubMed. Electronic databases were searched individually with specific search strings as this search method is more effective at identifying relevant articles than a simultaneous search using generic search terms. An initial search of databases was conducted in October 2013 for the time period 1993-2013 (16 October). Given evidence of the small number of peer reviewed studies in the Indigenous health field [14] , a 20 year time period was selected to obtain sufficient numbers of different types of studies to quantify changes in published Indigenous drug and alcohol research over time. The initial search identified 2421 references (after electronic removal of 1169 duplicate references). An updated search was conducted in July 2015 for the period 2013 to 2014, to extend the time period to December 2014. The 22 year period was selected to allow enough time for completion of the research and publication of the findings, balanced against limiting recall bias about studies completed too long ago. This updated search identified an additional 266 references (after electronic removal of duplicates). Combined, the initial and updated search identified 2687 citations/abstracts that were imported into Endnote.
Classification of studies
The abstracts of the 2687 identified references were examined and classified in a three-step process.
Step 1: Identification of studies for exclusion. Papers were excluded if: (i) Indigenous peoples of Australia, New Zealand, Canada or the USA were not the main study population (n = 601); (ii) alcohol or drugs was not the focus of the study (n = 568); (iii) they were not a journal article (n = 337); or (iv) they were a duplicate (n = 135).
Step 1 excluded 1641 publications, leaving 1046 remaining studies.
Step 2: Classification of studies. The remaining studies (n = 1046) were classified by research type using criteria derived and adapted from previous reviews [14] . Studies were initially classified into Data-based (n = 656), defined as original articles reporting new data or analysis of existing data, or Non-data based (n = 390), defined as research-reports of study protocols, commentaries, opinion articles, case studies or summaries of previous research (i.e. reviews).
Data-based studies were further categorised using a classification system employed in previous reviews [17] [18] [19] [20] : Measurement, defined as studies concerned primarily with developing drug or alcohol measurement instruments and/or testing their psychometric properties (n = 19); Descriptive, defined as quantitative or qualitative research exploring the frequency, patterns, or predictors of smoking, alcohol, or other drug use, or related variables, such as knowledge, attitudes, harms, perceptions or experiences. (n = 564); and Intervention, defined as evaluations or trials of interventions (e.g. programs, services or policies) designed to reduce drug or alcohol use and/or related harm, evaluations or trials of intervention approaches that included alcohol or other drugs as an outcome predictor variable, or evaluations of approaches for improving the uptake of drug or alcohol interventions by healthcare practitioners (n = 73). If a publication focused on both descriptive and intervention issues, it was classified as intervention research. If it focused on both measurement and descriptive issues, it was classified as measurement research.
A randomly selected sample of 100 articles (~20%) classified in step two were re-classified by a blinded research assistant to cross-check classifications performed by the first author. Agreement between coders was good (kappa = 0.62). Discrepancies were discussed and resolved. Because of sufficient agreement between Indigenous peoples drug and alcohol reviewcoders cross-checking more than 20% of classifications was deemed unnecessary.
Step 3: Classification of intervention studies. The abstracts of the 73 intervention studies were further classified using a modified version of a taxonomy for classifying drug and alcohol interventions [21] . The original taxonomy was rated highly in a review of schemes for classifying drug policy interventions [22] and includes four categories: law enforcement, prevention, treatment and harm reduction [23] . In applying the taxonomy to classify drug and alcohol interventions identified in this review, two modifications were made: first, the category law enforcement was replaced with supply reduction and included the subcategories of law enforcement and regulation, to distinguish between supply reduction strategies that use law enforcement and those that do not; and second, a fifth category, dissemination, was included to determine the extent to which strategies designed to integrate evidence distilled from drug and alcohol research into practice are being evaluated in Indigenous communities [24] . The five categories defined included: (i) Supply Reduction, defined as either 'law enforcement'-laws targeting individuals or sub-groups of drinkers that normally require police enforcement to be effective, such as alcohol free zones/bans on public drinking; or 'regulation'-laws that do not normally require active law enforcement, such as trading hours and bans on some types of alcohol sales; (ii) Prevention, defined as strategies to prevent or delay the onset or development of substance misuse problems or harms in individuals at risk; (iii) Treatment, defined as strategies designed to treat individuals with or at risk of drug or alcohol dependence; (iv) Harm reduction, defined as strategies designed to reduce harms from substance misuse in individuals and the community; and (v) Dissemination, defined as interventions designed to improve delivery of drug and alcohol interventions to Indigenous peoples.
Broad characteristics of intervention studies in each of the five categories were summarised using criteria related to the drug targeted, intervention type and setting, study design and outcomes measured. Cochrane's Effective Practice and Organisation of Care (EPOC) data collection checklist was used to classify intervention studies by their evaluation design [16] : randomised controlled trial (RCT), controlled clinical trial, controlled before and after study and interrupted time series. The checklist was chosen because it includes criteria to facilitate inclusion of non-experimental evaluation designs (i.e. those without randomisation or a control group). Evaluation designs not meeting EPOC criteria were classified as Non-EPOC.
Statistical analysis
All analyses were performed using STATA Version 13. Tests for significant differences in the overall distribution of studies used the χ2 statistic, reporting degrees of freedom (df) and the probability value (P). Fischer's exact test was used if any value in any cell was <5 [25] .
Results
Number of publications and percentage that were data based Figure 2 shows the number of data and non-data based drug and alcohol publications focused on Indigenous Table 1 shows the number and percentage of data-based publications classified into measurement, descriptive and intervention subcategories for each country in each time period.
Overall, data-based publications were predominately descriptive (564 of the 656 publications), comprising 84% ( The distribution of studies had not changed significantly across time periods (X2 = 1.6593 df = 2 P = 0.436). The distribution did not change significantly over time for any country (P > 0.05). Table 2 shows the number and percentage of measurement, descriptive and intervention studies for alcohol, tobacco, illicit and poly-drug use in each time period.
Tobacco and alcohol were the focus of 40% (n = 263) and 27% (n = 176) of data-based studies, respectively. Poly drug use was the focus of 19% of studies (n = 127), with alcohol (n = 78), cannabis (n = 62) and tobacco (n = 50) the three most common drugs targeted. Fourteen percent of studies targeted an illicit drug, most commonly cannabis, and 2% targeted inhalants. The distribution of studies over time periods did not change significantly for alcohol (P = 0.07), tobacco (P = 0.27), illicit (P = 0.74) or poly drug use (P = 0.69) publications. The change in the distribution of solvent publications could not be determined because of their zero number of intervention studies. Broad characteristics of intervention studies Prevention interventions primarily evaluated education (n = 10 studies) and mass media (n = 6 studies) strategies targeting tobacco or alcohol. Drug use was a primary outcome measure for 20 out of 25 prevention interventions.
Thirteen out of 22 treatment interventions evaluated pharmacotherapies, alone or in combination with a behavioural intervention (i.e. counselling). Tobacco (n = 10 studies) was the drug most commonly targeted by treatment interventions. Drug use was a primary outcome measure for 20 out of 22 treatment interventions, followed by drug-related harms (n = 7 studies).
Ten out of 11 supply reduction interventions evaluated community level alcohol restrictions. Alcohol-related harms were a primary outcome measure for almost two-thirds of these types of interventions (n = 7 studies), followed by alcohol use (n = 4 studies).
Four out of seven harm reduction interventions evaluated multiple strategies targeting alcohol, three of which identified alcohol use as the primary outcome measure. Dissemination interventions evaluated strategies to improve the uptake of alcohol and/or tobacco interventions in primary health care or community settings. Table 4 summarises the number and percentage of intervention studies employing EPOC and non-EPOC evaluation designs.
Study designs employed by intervention studies
Of the 73 intervention studies, 41% (n = 30) employed an EPOC (13 controlled before and after; 10 randomised controlled trials and 7 interrupted time series) and 59% (n = 43) a non-EPOC (30 single before and after; 10 post-test; and 1 each of case study, cross-sectional and longitudinal cohort) evaluation design. The percentage Indigenous peoples drug and alcohol review Indigenous peoples drug and alcohol review 
Discussion
This review examined broad patterns of Indigenous drug and alcohol research output over the past 20 years. Encouragingly, the proportion of publications that were data based increased steadily over the time period. Less encouraging, 86% of all data-based publications were descriptive studies, with only 11% assessing the effectiveness of interventions. This predominance of descriptive studies was consistent for all time periods, countries and types of drugs. This finding is consistent with that of previous reviews examining research output in the drug and alcohol [20, 26, 27] and Indigenous health [14, 28] fields. This indicates that, as with drug and alcohol and Indigenous health research generally, the development of intervention research in the Indigenous drug and alcohol field is progressing slowly, limiting the amount and quality of evidence available to inform policies and programs implemented to reduce drug and alcohol harms in Indigenous communities. Compounding this is the small number of dissemination studies, which, consistent with previous research [24, 29, 30] , suggests that the implementation of evidence distilled from drug and alcohol research in Indigenous communities is not being rigorously evaluated and the results consistently published in the peer review literature.
Measurement articles constituted 0-9% of research publications for all time periods, countries and drug types. This is less than optimal, considering that valid and reliable measurement tools are required for rigorous descriptive and intervention research. Tobacco and alcohol publications had a lower percentage of measurement studies than illicit and poly-drug use publications. Given that tobacco and alcohol accounted for 40% and 27% of data-based publications, respectively, it might have been expected that a larger percentage of research outputs in these fields would have been allocated to developing and testing measurement tools. If the validity and reliability of tobacco and alcohol measures are not rigorously established for Indigenous peoples, the accuracy of prevalence data examining patterns of use, outcome data assessing the effect of interventions designed to reduce use and screening instruments to detect individuals with at risk use are likely to be questionable. For example, in their critique of a national survey of Indigenous alcohol use in Australia, Chikritzhs and Brady found that less than optimal measures contributed to an underestimation of Indigenous alcohol use [31] . They concluded that an understanding of Indigenous cultures and drinking patterns are required to obtain reliable and accurate measures of Indigenous alcohol use. Encouragingly, there is some evidence from the relatively small number of drug and alcohol measurement studies conducted in Indigenous communities of researchers working with Indigenous communities to develop reliable and accurate measures of Indigenous drug and alcohol use that are culturally appropriate and acceptable to Indigenous peoples [32] [33] [34] [35] [36] .
Intervention studies
The variations in the number and types of interventions evaluated may reflect differences in prevalence and harms, and levels of funding and political support for alcohol, tobacco and illicit drugs. The dominance of alcohol and tobacco intervention evaluations is consistent with Indigenous peoples experiencing a higher burden of harm from alcohol and tobacco than other drugs [3, 5] . Similarly, the higher percentage of treatment interventions for smoking is consistent with tobacco smoking being a leading behavioural risk factor of death and disease in Indigenous populations [37] . Although the percentage of research that is intervention is highest for tobacco, it is concerning that the percentage of tobacco intervention research has remained low from 1993-2000 (15%) to 2008-2014 (9%) . This low proportion of tobacco intervention research is a particular problem for Indigenous peoples because they are over-represented in low-socioeconomic status sub-populations [37] and rates of smoking remain high among these populations [38] .
With regard to alcohol, the dominance of supply reduction interventions in Australia possibly reflects the disproportionately high burden of alcohol harms in remote Indigenous Australian communities [9] , and widespread political support for community-level alcohol restrictions to reduce risky alcohol consumption and related harms [39] . It might also reflect the relative ease of implementing these strategies, compared with the time, commitment and high levels of engagement required to successfully implement more participatory alcohol intervention approaches in Indigenous communities [40] . A recent review of Indigenous community studies published between 1990 and 2015 has shown that despite much rhetoric about the importance of community development interventions designed, implemented and evaluated in partnership with Indigenous communities, only 31 such evaluations were published in this 25 year period, and they were of low methodological quality [41] . In clinical settings, it might similarly have been expected that a greater number of studies reporting the cost-effectiveness of alcohol interventions for Indigenous peoples would have been published, considering the high strength of the evidence base for alcohol brief interventions delivered in non-Indigenous clinical settings [42] and their relatively low rates of delivery to Indigenous Australians in primary health care [43] .
Only 41% (n = 30) out of 73 intervention studies employed an EPOC evaluation design. The dominance of non-EPOC designs is consistent with findings of previous reviews of Indigenous health research, which found that few study designs used to evaluate drug and alcohol interventions specifically targeting Indigenous peoples employ randomisation and a control group [44] [45] [46] [47] . The RCT is the most rigorous study design, but its implementation is not always feasible [48] , particularly in Indigenous communities [49] ; only one third of EPOC evaluation designs employed an RCT. Practical and methodologically rigorous study design alternatives for increasing the output of robust intervention studies in the Indigenous drug and alcohol field should therefore be considered. Encouragingly, there is recent evidence of researchers in the Indigenous drug and alcohol field implementing methodologically rigorous alternatives to RCTs, such as the Multiple Baseline design (MBD) [50] [51] [52] [53] . Methodologically, this design staggers the implementation of interventions across multiple sites with each site acting as a comparative control for other sites for the period before it receives the intervention [54] . Practically, the MBD is more cost and time-efficient than RCTs and more feasible for evaluating public health, policy and community-level interventions [55] . Despite its methodological rigour and practical benefits, no intervention study in this review employed the MBD and few employed similar alternatives. The process of implementing methodologically rigorous alternatives, and RCTs, as described by researchers currently utilising them to evaluate Indigenous drug and/or alcohol interventions, strongly suggests that partnerships between researchers, Indigenous communities and healthcare providers are required, to enable researchers' methodological skills and expertise to be combined with community members' local knowledge and experience, and healthcare providers' expertise in designing and implementing services and programs [50] [51] [52] [53] .
Limitations of methodology
Grey literature publications were not included as they have not been subject to peer review. As well-designed studies are likely to be published in peer-reviewed journals [56] , it seems unlikely that rigorous studies would have been under-represented. There may be disagreement over the classification system used to categorise types of research output. The classification system has, however, been used in previous reviews of Indigenous health research [14] , enabling comparison of outputs of Indigenous drug and alcohol research with Indigenous health research more broadly. It also provides a useful indicator for those working in the Indigenous drug and alcohol field of the potential for outputs being produced to inform policy and practice. Publications may have been misclassified, although good agreement (kappa = 0.62) between blinded coders suggests not. Study design was the main indicator used to assess the quality of intervention studies. Indicators related to implementation of a study design (e.g. selection bias, confounding, attrition) were not examined. Study designs may have been implemented in a way that compounded weaknesses and compromised strengths inherent in their design. Differences in inherent methodological strengths and weaknesses across study designs (e.g. random vs. non-random and single vs. two group designs) however, make them an adequate indicator of the methodological quality of an intervention evaluation [16] .
Conclusion
While there has been an increase in the number and percentage of data-based publications in the Indigenous drug and alcohol field, the pattern of research output suggests a dominance of descriptive research and a paucity of intervention and measurement research, at least over the past two decades. Compounding the lack of intervention research has been the small number of interventions evaluated using methodologically rigorous study designs. If mechanisms to increase the frequency and quality of intervention research in the Indigenous drug and alcohol field are not implemented, evidence for informing Indigenous drug and alcohol policy and programs is likely to be inconclusive or absent. Research institutions and funding organisations should therefore consider the findings of this review when allocating research resources in the Indigenous drug and alcohol field. The overall findings of this review suggest that greater priority should be given to allocating research resources to studies with the greatest potential to reduce Indigenous drug and alcohol-related harms through the application of evidence-based practice.
